Related Experiment Video

Updated: Aug 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot

Lilia Grodzińska1, Dorota Starzyk, Krzysztof Bieroń

  • 1Department of Pharmacology, Department of Clinical Pharmacology, Jagiellonian University School of Medicine, 31-531 Cracow, 16 Grzegorzecka, Poland.

Basic & Clinical Pharmacology & Toxicology
|May 25, 2005
PubMed

Insights

Simvastatin improves endothelial function and walking distance in patients with peripheral arterial occlusive disease, independent of cholesterol levels. These benefits stem from statins' pleiotropic effects, enhancing vascular health.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statin-induced improvements in endothelial function are attributed to pleiotropic effects, not solely cholesterol reduction.
  • Peripheral arterial occlusive disease (PAOD) is characterized by impaired endothelial function and reduced walking capacity.

Purpose of the Study:

  • To investigate the biological effects of simvastatin on endothelial function in normocholesterolemic and hypercholesterolemic PAOD patients.
  • To assess simvastatin's impact on clinical outcomes, including walking distance and vascular markers.

Main Methods:

  • A pilot study involving 20 PAOD patients (10 normocholesterolemic, 10 hypercholesterolemic) treated with simvastatin 40 mg/day for 3 months.
  • Measurements included lipid profiles, ankle-brachial index, flow-mediated dilation, euglobulin clot lysis time, and platelet aggregation.
  • Clinical assessment of pain-free and total walking distance was performed.

Main Results:

  • Simvastatin significantly reduced cholesterol and triglyceride levels in both groups.
  • Flow-mediated dilation increased substantially in both normocholesterolemic (153%) and hypercholesterolemic (180%) groups.
  • Walking distance improved, euglobulin clot lysis time shortened, and platelet aggregation was modulated, indicating enhanced endothelial function and reduced thrombotic potential.

Conclusions:

  • Simvastatin therapy improves endothelial function and clinical outcomes in PAOD patients, irrespective of baseline cholesterol levels.
  • The observed benefits are likely mediated by simvastatin's pleiotropic effects, restoring endothelial function and improving vascular health.

More Related Videos

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...